WB-4101,是一种化合物,可以作α1B-肾上腺素能受体的拮抗剂。1969年,WB-4101是首批为该受体开发的选择性拮抗剂之一,常用于肾上腺素受体的研究,作为开发更具选择性药物的先导化合物。[1][2][3][4][5][6]
Quick Facts 识别信息, CAS号 ...
WB-4101 |
|
2-(2,6-Dimethoxyphenoxyethyl)aminomethyl-1,4-benzodioxane
|
CAS号 | 613-67-2 Y |
---|
PubChem CID | |
---|
IUPHAR/BPS | |
---|
ChemSpider | |
---|
UNII | |
---|
CompTox Dashboard (EPA) | |
---|
|
化学式 | C19H23NO5 |
---|
摩尔质量 | 345.389 |
---|
3D模型(JSmol) | |
---|
COc1cccc(c1OCCNCC2COc3ccccc3O2)OC
|
InChI=1S/C19H23NO5/c1-21-17-8-5-9-18(22-2)19(17)23-11-10-20-12-14-13-24-15-6-3-4-7-16(15)25-14/h3-9,14,20H,10-13H2,1-2H3 Key:GYSZUJHYXCZAKI-UHFFFAOYSA-N
|
Close
The synthesis and pharmacological properties of a series of 2-substituted aminomethyl-1,4-benzodioxanes. Journal of Medicinal Chemistry. March 1969, 12 (2): 326–9. PMID 5791620. doi:10.1021/jm00302a033.
Characterization of alpha 1-adrenergic receptor subtypes in rat brain: a reevaluation of [3H]WB4104 and [3H]prazosin binding. Molecular Pharmacology. April 1986, 29 (4): 321–30. PMID 3010073.
Affinity and activity profiling of unichiral 8-substituted 1,4-benzodioxane analogues of WB4101 reveals a potent and selective α1B-adrenoceptor antagonist. European Journal of Medicinal Chemistry. December 2012, 58: 184–91. PMID 23124215. doi:10.1016/j.ejmech.2012.09.049.
6-methoxy-7-benzofuranoxy and 6-methoxy-7-indolyloxy analogues of 2-[2-(2,6-Dimethoxyphenoxy)ethyl]aminomethyl-1,4-benzodioxane (WB4101):1 discovery of a potent and selective α1D-adrenoceptor antagonist. Journal of Medicinal Chemistry. August 2013, 56 (16): 6402–12. PMID 23902232. doi:10.1021/jm400867d.